Kprx stock price.

View the full S&P 500 Index (SPX) index overview including the latest stock market news, data and trading information.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...Find the latest Structure Therapeutics Inc. (GPCR) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Kiora Pharmaceuticals Inc (KPRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Get the latest Kiora Pharmaceuticals, Inc. (KPRX) stock news and headlines to help you in your trading and investing decisions.

With Kiora Pharmaceuticals stock trading at $0.53 per share, the total value of Kiora Pharmaceuticals stock (market capitalization) is $4.07M. Kiora Pharmaceuticals stock was originally listed at a price of $3,600.00 in Feb 13, 2015.Share/Stock Market - LIVE BSE/NSE, Nifty Sensex Share Price, Stock Exchange, Top Gainers and Losers Stocks, Returns and Trading. Get Online Stock Trading News, Analysis on Equity and Stock Markets Tips, Sensex, Nifty, Commodities and more.

Find the latest Phillips 66 (PSX) stock quote, history, news and other vital information to help you with your stock trading and investing.The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32.Nov 27, 2023 · Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of 7,117.39%. The lowest target is $2.00 and the highest is $119. On average, analysts rate KPRX stock stock as a strong buy. Feb 7, 2023 ... ... stock price. Economic Trends and Government Policies. In addition to ... KPRX Stock News. This week's headlines focus on KIO-101 and a related ...$176.65 UNCH TSLA Tesla, Inc. Common Stock $220.20 +0.24 +0.11% NVDA NVIDIA Corporation Common Stock $450.47 +0.42 +0.09% MSFT Microsoft Corporation Common Stock $352.60 -0.20 -0.06%...

62.85M. —. Price to book. A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock. 2.50. —. Return on assets. A ...

The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. Learn more on CPRX's analyst rating history. Do Wall Street analysts like Catalyst Pharmaceuticals more than its competitors? Analysts like Catalyst Pharmaceuticals more than other Medical companies.

Find the latest TAL Education Group (TAL) stock quote, history, news and other vital information to help you with your stock trading and investing.KPRX price to book (PB)For valuing companies that are loss-making or have lots of physical asset. Company. 0.5x. Industry. 5.36x. ... Kiora Pharmaceuticals 's market cap is calculated by multiplying KPRX's current stock price of $0.53 by KPRX's total outstanding shares of 7,689,240.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Feb 10, 2023 ... ... price targets on the company's stock and three raising them. ... Kiora Pharmaceuticals (KPRX) shares zoomed 109% this week from $3.28 on Monday ...If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...View the MarketWatch summary of the U.S. stock market with current status of DJIA, NASDAQ, S&P, DOW, NYSE and more.

Who Owns Kiora Pharmaceuticals, Inc. (KPRX) Kiora Pharmaceuticals, Inc. (KPRX) is a publicly traded company, meaning that its ownership is spread across a large number of shareholders who own the company's stock. The largest shareholders of Kiora Pharmaceuticals, Inc. are institutional investors, such as mutual funds, pension funds, …The Price and 12 Month EPS chart displays the company's stock price along with the trailing twelve month (TTM) EPS. A company's earnings per share, or EPS, is a key financial metric on its income ... Get the latest Kiora Pharmaceuticals, Inc. (KPRX) stock news and headlines to help you in your trading and investing decisions. KPRX -4.69%. 39. See KPRX Report. Kiora Pharmaceuticals Inc ( KPRX) is down Friday morning, with the stock losing -36.53% in pre-market trading to 1.06. KPRX's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 66 out ...News Ideas Financials Technicals Forecast KPRX chart Today −0.69% 5 days −7.26% 1 month −4.17% 6 months −72.49% Year to date −83.43% 1 year −91.21% 5 years …Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing.According to 3 analysts, the average rating for KPRX stock is "Strong Buy." The 12-month stock price forecast is $41.5, which is an increase of 8,122.71% from the latest price. Price Target

Kiora Pharmaceuticals last announced its quarterly earnings results on November 9th, 2023. The reported ($0.89) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by $0.59. Kiora Pharmaceuticals has generated $0.00 earnings per share over the last year.

Kiora Pharmaceuticals 's market cap is calculated by multiplying KPRX's current stock price of $0.53 by KPRX's total outstanding shares of 7,689,240. In today’s recent session, 1.34 million shares of the Kiora Pharmaceuticals Inc (NASDAQ:KPRX) have been traded, and its beta is -0.26. Most recently the company’s share price was $0.61, and it changed around -$0.01 or -1.53% from the last close, which brings the market valuation of the company to $4.43M. KPRX at last check was trading at a ...View the latest Prudential Financial Inc. (PRU) stock price, news, historical charts, analyst ratings and financial information from WSJ.Kiora Pharmaceuticals, Inc. (KPRX.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Kiora Pharmaceuticals, Inc. | Nasdaq ...Kiora Pharmaceuticals Inc stock price (KPRX) NASDAQ: KPRX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Kiora Pharmaceuticals Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock quote, history, news and other vital information to help you with your stock trading and investing.TNXP's stock price has decreased by -78.66% in the past year and price targets may not have had time to catch up. Stock Price Forecast. According to 1 stock analyst, the 12-month stock price forecast for TNXP stock stock is $8.00, which predicts an increase of 1,453.40%. On average, analysts rate TNXP stock stock as a strong buy.Find the latest Unique Fabricating, Inc. (UFAB) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Kiora Pharmaceuticals, Inc. (KPRX) stock news and headlines to help you in your trading and investing decisions.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Price Analysis: The pricing strategy adopted by Kiora Pharmaceuticals, Inc. ... Stock Exchanges. AMEX · NASDAQ · NYSE. Recent Posts. Recent Posts. Mastering ...

Dec 1, 2023 · Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend. Nov 25, 2023 · Get Kiora Pharmaceuticals Inc (KPRX.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision. Learn more about our companyKiora Pharmaceuticals (KPRX) Stock Price, Quote, News & Analysis - TipRanks.com. Analyst ForecastsNews & Insights. TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions. Kiora Pharmaceuticals (KPRX) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst ...The latest Kiora Pharmaceuticals stock prices, stock quotes, news, and KPRX history to help you invest and trade smarter.KPRX Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Pharmaceuticals. KIORA PHARMACEUTICALS, INC. (KPRX) Compare. KIORA PHARMACEUTICALS, ...ACMR Stock 12 Months Forecast. $24.50. (39.05% Upside) Based on 5 Wall Street analysts offering 12 month price targets for ACM Research in the last 3 months. The average price target is $24.50 with a high forecast of $32.00 and a low forecast of $19.50. The average price target represents a 39.05% change from the last price of $17.62.Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing.3 brokers have issued 1-year price targets for Kiora Pharmaceuticals' stock. Their KPRX share price targets range from $7.00 to $119.00. On average, they anticipate the company's stock price to reach $46.00 in the next year. This suggests a possible upside of 8,955.1% from the stock's current price. View analysts price targets for KPRX or view ...KPRX’s Market Performance. The stock of Kiora Pharmaceuticals Inc (KPRX) has seen a 11.98% increase in the past week, with a 9.98% rise in the past month, and a 19.87% gain in the past quarter. The volatility ratio for the week is 4.03%, and the volatility levels for the past 30 days are at 5.80% for KPRX. The simple moving average for the ...Get the latest Eli Lilly And Co (LLY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Get the latest Boeing Co (BA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.The reverse stock split caused the price of KPRX stock to jump from its prior value of 18 cents per share when markets closed on Monday. This saw the stock opening on Tuesday at a price of $6.18.Jul-26-22 04:38PM. Kiora Pharmaceuticals Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option. (Newsfile) Jul-22-22 08:30AM. Kiora Pharmaceuticals Announces Pricing of $5.2 Million Underwritten Public Offering. (Newsfile) -39.76%.Instagram:https://instagram. vanguard intermediate term bond etfplanet fitness billing companydell inc share price20 stocks KPRX Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 19:59:42. $6.39. 4.Kiora Pharmaceuticals Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-1.740 per share for the current fiscal year. Kiora Pharmaceuticals Inc does not currently pay a dividend. aapl target pricenasdaq ltbr H.C. Wainwright Sticks to Their Buy Rating for Kiora Pharmaceuticals (KPRX) August 24, 2023TipRanks. Kiora Pharmaceuticals price target lowered to $2 from $7 at H.C. Wainwright August 14 ... schwab bonds ACMR Stock 12 Months Forecast. $24.50. (39.05% Upside) Based on 5 Wall Street analysts offering 12 month price targets for ACM Research in the last 3 months. The average price target is $24.50 with a high forecast of $32.00 and a low forecast of $19.50. The average price target represents a 39.05% change from the last price of $17.62.On Friday, Kiora Pharmaceuticals Inc (KPRX:NAQ) closed at 0.6335, 37.06% above the 52 week low of 0.4622 set on Sep 05, 2023. Data delayed at least 15 minutes, as of Nov 10 2023 20:59 GMT. Latest Kiora Pharmaceuticals Inc (KPRX:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.